SCHEMBL18968643

SCHEMBL18968643

COC(=O)Cn1c(-c2ccccc2)[n+](C)c2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 9/20 0.57
▸ MEN1 O00255 6/20 0.57
▸ MAPK1 P28482 5/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.57
▸ HTT P42858 5/20 0.57
▸ MITF O75030 4/20 0.57
▸ LMNA P02545 4/20 0.57
▸ NPSR1 Q6W5P4 3/20 0.57
▸ TP53 P04637 2/20 0.57
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ KDM4E B2RXH2 5/20 0.52
▸ ALDH1A1 P00352 5/20 0.50
▸ MAPT P10636 3/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ HSD17B10 Q99714 3/20 0.47
▸ HPGD P15428 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ GLA P06280 1/20 0.45
▸ GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18968635 0.91 MAPK1 (0.50) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968673 0.88 MAPK1 (0.48) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968636 0.88 HTT (0.55) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968669 0.87 KMT2A (0.48) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968675 0.84 KMT2A (0.44) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968650 0.83 KDM4E (0.58) KMT2AMEN1SMN1; SMN2NPC1KDM4E
SCHEMBL18968668 0.81 HTT (0.48) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18968671 0.81 SMN1; SMN2 (0.47) KMT2AMEN1MAPK1SMN1; SMN2HTT
SCHEMBL18970013 0.80 KDM4E (0.54) KMT2AMEN1SMN1; SMN2NPC1KDM4E
SCHEMBL18968672 0.77 KMT2A (0.50) KMT2AMEN1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017100525-A1 SUBSTITUTED BENZIMIDAZOLIUM, PYRIDO-IMIDAZOLIUM, OR PYRAZINO-IMIDAZOLIUM COMPOUNDS AS CHEMOTHERAPEUTICS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-06-15 — — WO disclosed
Send feedback